A partnership between Purdue and Huston Methodist Research Institute is designed to translate basic research into life-changing treatments.
The two entities signed a memorandum of understanding on the West Lafayette campus Wednesday.
Purdue president Mitch Daniels says the collaboration helps advance one of the priorities of the Purdue Moves initiative— drug discovery.
He says partnering with the Huston Methodist Research Institute is necessary because Purdue doesn’t have a medical school.
“So it’s necessary and it’s very natural for us to look for the very best partner on the planet who can evaluate the discoveries made here at Purdue and translate them into new medicines and new technologies to save and improve lives,” Daniels said.
Daniels says under the agreement, Purdue faculty and graduate students will have full access to the Institute’s facilities and staff to help make the path from discovery to the marketplace more efficient.
Philip Low is a Chemistry professor and the inaugural director of the Purdue Center for Drug Discovery.
He says the goal is to find cures for diseases such as Alzheimer’s, Parkinson’s, and cancer, and to get those drugs to the patients who need them as soon as possible.
“With the strengths that we have at Purdue in discovering new drugs, Houston Methodist makes an ideal partner to really complete the entire journey from discovery to delivery,” Low said. “This has been a major mission of Purdue University to in fact and take all the basic science and make it useful to mankind.”